Our mission is to help people with diabetes to live more normal and longer lives. We are using our proprietary Biomimetic Glucose Binding Molecules (GBM) to develop a new glucose sensor chemistry what will enable market-leading Continuous Glucose Monitors (CGM).
Our GBMs offer unparalleled selectivity towards glucose and function in even the most complex biological mixtures.
STABLE & VERSATILE
Our GBMs are extremely robust with a multi-year operational potential.
Carbometrics’ GBMs are produced by a streamlined, scalable synthesis and are readily derivatised for bioconjugation and chemical synthesis.
Carbometrics is a specialist chemistry company based in Bristol, UK. Our core competency is the design, synthesis and derivatisation of highly selective and robust carbohydrate-binding molecules. Our technology is based on over 20 years of cutting-edge research pioneered by Professor Anthony Davis’ group at the University of Bristol. Carbometrics’ goal is to exploit our GBM technology to realise a highly robust and accurate glucose sensing platform that can be used to create a market-leading Continuous Glucose Monitoring (CGM) solution. The company was set up after the founders sold their first company Ziylo to Novo Nordisk, which is using the same platform to develop smart insulins.